Congratulations to Dr Irakli Gogorishvili and his colleagues at Healthycore Clinic on this important milestone in the hashtag#ELEVATEIV First-in-Human study. Supporting a cardiogenic shock patient with a 10 Fr fully sheathed, over-the-wire Elevate™ pLVAD delivering >5.4 L/min mean flow and >8.4 L/min peak flow is a remarkable technical and clinical achievement.

Magenta Medical Ltd.’s Elevate™ technology represents a true step forward in mechanical circulatory support, combining miniaturization with powerful hemodynamic performance in a way that can meaningfully impact acute heart failure and cardiogenic shock care.

At Clinical Accelerator, we are proud to support the growing portfolio of complex heart failure and mechanical circulatory support device studies in Georgia. The successful execution of advanced First-in-Human investigations such as ELEVATE IV reflects the deepening expertise of Georgian investigators and study teams, as well as the region’s readiness for high-acuity cardiovascular research.

A strong collaboration, a great achievement for Magenta Medical Ltd., and another important step in establishing Georgia as a credible hub for next-generation heart failure device trials.